narcolepsy

Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep
Biotech

Alkermes impresses in full-throttle narcolepsy race with Takeda

The phase 1b readout suggests Alkermes’ ALKS 2680 can hold its own against Takeda’s rival prospect despite being administered less frequently.
Nick Paul Taylor Jun 4, 2024 9:01am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Phase 2b narcolepsy win powers Takeda toward pivotal trials

Feb 9, 2024 6:02am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Jazz halts sleep disorder med trial over 'visual disturbances'

Nov 29, 2023 10:50am
Takeda HQ

Takeda cuts ties to cancer drug landed in $120M Turnstone deal

Jul 28, 2022 7:00am
visual of drugs being inspected by a magnifying glass

With narcolepsy approval a year out, antsy Avadel slashes staff

Jun 30, 2022 11:04am
bad sleep sleep disorder timeline alarm clock deadline

Avadel's shares crumble as narcolepsy drug delayed yet again

May 26, 2022 10:53am